Aclaris Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 14.25 M | $35.34 M | 0.00% | 19.96% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 9.63 M | $23.88 M | 100.00% | 13.49% |
| VIVO CAPITAL, LLC | 02/13/2025 | 8.89 M | $22.04 M | 100.00% | 12.45% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 6.20 M | $15.39 M | 125.32% | 8.69% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.67 M | $11.57 M | 100.00% | 6.54% |
| VANGUARD GROUP INC | 02/11/2025 | 4.33 M | $10.73 M | -7.69% | 6.06% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 3.29 M | $8.17 M | -2.32% | 4.61% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.80 M | $6.99 M | 100.00% | 3.92% |
| MARSHALL WACE, LLP | 02/13/2025 | 2.63 M | $6.53 M | 100.00% | 3.69% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 2.39 M | $5.91 M | 242.60% | 3.34% |
| DECHENG CAPITAL LLC | 02/14/2025 | 2.27 M | $5.62 M | 100.00% | 3.18% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 2.22 M | $5.51 M | 100.00% | 3.11% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.96 M | $4.86 M | -34.82% | 2.74% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.74 M | $4.32 M | -16.08% | 2.44% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.26 M | $3.12 M | -26.52% | 1.76% |
| ALDEBARAN CAPITAL, LLC | 02/12/2025 | 1.02 M | $2.52 M | -2.51% | 1.42% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 977,400 | $2.42 M | -24.90% | 1.37% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 923,313 | $2.29 M | 0.00% | 1.29% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 908,819 | $2.25 M | 173.41% | 1.27% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/14/2025 | 888,888 | $2.20 M | 100.00% | 1.25% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 850,519 | $2.11 M | -37.95% | 1.19% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 839,270 | $2.08 M | -7.56% | 1.18% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 789,597 | $1.96 M | -6.72% | 1.11% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 718,897 | $1.78 M | 100.00% | 1.01% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 663,405 | $1.65 M | -73.02% | 0.93% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 615,083 | $1.53 M | 110.04% | 0.86% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 569,832 | $1.41 M | 0.00% | 0.80% |
| JANE STREET GROUP, LLC | 02/14/2025 | 545,564 | $1.35 M | 559.48% | 0.76% |
| FMR LLC | 02/13/2025 | 459,049 | $1.14 M | -15.92% | 0.64% |
| AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 434,455 | $1.08 M | 0.00% | 0.61% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 428,587 | $1.06 M | 42.13% | 0.60% |
| 01/29/2025 | 404,452 | $1.00 M | 100.00% | 0.57% | |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 397,362 | $985,458 | 113.89% | 0.56% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 389,333 | $965,546 | 100.00% | 0.55% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 350,000 | $868,001 | 100.00% | 0.49% |
| STATE STREET CORP | 02/14/2025 | 319,275 | $791,802 | 69.18% | 0.45% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 292,892 | $726,372 | 108.35% | 0.41% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 281,119 | $697,175 | 41.18% | 0.39% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 262,948 | $652,111 | -14.02% | 0.37% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 256,092 | $635,108 | 3,573.68% | 0.36% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 239,595 | $594,195 | 211.93% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 230,300 | $571,144 | 749.82% | 0.32% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 217,265 | $538,817 | 100.00% | 0.30% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 154,351 | $382,790 | 100.00% | 0.22% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 131,895 | $327,099 | 100.00% | 0.18% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 123,100 | $306,000 | -11.69% | 0.17% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 112,484 | $278,960 | 100.00% | 0.16% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 106,351 | $263,750 | 100.00% | 0.15% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 100,000 | $248,000 | 100.00% | 0.14% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 93,547 | $231,997 | 141.14% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 133 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 9.63 M
Vivo Capital, LLC: 8.89 M
Rock Springs Capital Management LP: 6.2 M
RA CAPITAL MANAGEMENT, L.P.: 4.67 M
VANGUARD GROUP INC: 4.33 M
122.55% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 93.99 M shares in the last 24 months. This purchase volume represents approximately $237.80 M in transactions.